DMERx Kingpin Convicted in $1B Medicare Fraud: How a Single Platform Industrialized Elderly Exploitation
Brett Blackman, the 42-year-old CEO of HealthSplash, was convicted of running what federal prosecutors call one of Florida's most egregious fraud schemes—a telemedicine-to-equipment pipeline that extracted over $450 million from Medicare by targeting vulnerable elderly beneficiaries with medically unnecessary orthotic braces.
The conviction arrived quietly in early May, buried in the news cycle between hospice takedowns and congressional fraud hearings. But what prosecutors documented in the southern district of Florida represents the exact mechanics of industrial-scale Medicare exploitation that drives federal enforcement today: a software platform, foreign call centers, telemedicine doctors willing to sign orders without examining patients, and a clearinghouse of durable medical equipment suppliers—all connected by illegal kickbacks and document manipulation.
Blackman, 42, owned and operated HealthSplash, which acquired the Power Mobility Doctor Rx platform (DMERx) in 2017. The platform became the infrastructure for predatory targeting. Foreign call centers blasted Medicare's most vulnerable population—elderly beneficiaries identified through data brokers—with aggressive telemarketing campaigns pushing orthotic braces nobody needed. When beneficiaries agreed under pressure, the leads flowed into telemedicine companies with pre-arranged relationships with doctors. Those physicians signed orders certifying they had personally examined the patient, when in many cases—as government undercover agents documented—the doctor never spoke with them at all.
Once the fraudulent doctors' orders were signed, Blackman's DME supply companies or his co-conspirators' companies billed Medicare directly. The fraud generated more than $1 billion in false claims across the conspiracy. Medicare paid out $450 million. Blackman personally pocketed over $10.4 million in direct proceeds before investigators froze his assets.
The concealment layer mattered. Blackman didn't just run the scheme—he engineered its invisibility. Prosecutors found that he and his co-conspirators manipulated physicians' orders to evade Medicare's automated audits and used sham contracts to disguise the illegal kickback flows. When agents posed as actual Medicare beneficiaries, the operation exposed itself: a foreign call center pushed the undercover agent into multiple unnecessary braces, then a DMERx doctor signed clinical examination reports for tests that were "physically impossible to perform remotely."
Blackman's co-defendant Gary Cox, who ran DMERx directly, was convicted and sentenced to 15 years in prison in June 2025. Federal prosecutors sought the maximum available—20 years for healthcare and wire fraud, plus an additional five years for kickback conspiracy. Blackman's sentencing is scheduled for August 26, 2026.
But the conviction illuminates something more consequential than one criminal enterprise: it demonstrates how telemedicine—a sector explicitly designed to reduce healthcare costs and reach underserved populations—became a fraud vector. Telemedicine providers could sign orders without real medical relationships. Verification loops didn't exist. And the economic incentive structure rewarded volume, not patient outcomes.
This wasn't happenstance. In the DOJ's 2025 National Health Care Fraud Takedown, 49 defendants were charged in connection with over $1.17 billion in fraudulent telemedicine and genetic testing claims alone. That operation snared dozens of similar schemes operating the same playbook: telemarketing to vulnerable beneficiaries, telemedicine signoffs on unnecessary equipment, equipment suppliers as the actual fraud engine.
The bigger story emerges when you stack the convictions. The Health Care Fraud Unit has completed nine trials in 2026 so far—all convictions—involving over $1.1 billion in fraud across six distinct schemes. Two weeks ago, CMS announced it was suspending Medicare payments to hundreds of potentially fraudulent hospice providers without waiting for criminal conviction. Days before that, the agency issued nationwide moratoria on new Medicare enrollments for hospices, home health agencies, and durable medical equipment suppliers. The administration suspended $5.7 billion in suspicious payments in 2025 alone.
The enforcement crescendo reflects institutional acknowledgment of what was long buried in billing data: Medicare's design creates structural incentives for fraud. Services rendered remotely are hard to verify. Beneficiary consent is rarely documented. Billing codes allow extraordinary variation in reimbursement rates. A provider billing at the 90th percentile looks different from one at the 10th percentile, but the difference may be explained by patient composition—or by aggressive upcoding.
Blackman made the mistake of getting rich too visibly. He appeared in a music video showing off a waterfront mansion and wearing a large gold dollar-sign necklace. That hubris, and the sheer scale of the operation, made him prosecutable. But the structural conditions that enabled $1 billion in false claims—the telemedicine platform, the foreign call centers, the pre-arranged physician approvals, the DME supply chain—remain intact in dozens of other operations not yet detected or prosecuted.
Here's what matters: Blackman's conviction proves that Medicare fraud isn't a compliance problem—it's an architecture problem. A 42-year-old with a software platform, some capital, and willingness to break the law extracted $450 million from an elderly population in a scheme that was theoretically detectable by automated review systems at every step. It wasn't. Because detection requires CMS to invest in backend monitoring that politicians have never funded adequately, and because the incentive structures embedded in Medicare—unlimited benefit promises, high reimbursement rates, minimal upfront verification—make fraud economically rational for bad actors. If Blackman gets 20 years and his assets are seized, nothing changes for the next operator using the same playbook. The administration's new moratorias on hospice and DME enrollment are defensive theater. They freeze the door while keeping the broken lock in place. Until Medicare's billing architecture fundamentally changes—moving from "pay and chase" to real-time verification, beneficiary consent documentation, and reimbursement rate compression—we're just rotating which fraudsters get caught while the underlying leak keeps flowing.
Cross-reference independently — don't take our word for it.
Disclosure: NewsAnarchist uses AI-assisted reporting with web search. Always verify primary sources linked above.